Tolypocladium inflatum is a pathogenic fungus of beetle larvae, belonging to the Ophiocordycipitaceae family, which is the third family of insect pathogenic fungi within the fungal order
Hypocreales (
1). Fungi of the
Hypocreales order produce a variety of toxic non-ribosomal cyclic peptides with antimicrobial, insecticidal, and cytotoxic activities (
2). Cyclosporin A (CyA) (
Figure 1B) is one of these cyclic undecapeptides, synthesized by the ascomycete fungus
T. inflatum, and possesses immunosuppressive, insecticidal, and antifungal properties (
3). The CyA was first discovered in 1973 and was approved by the FDA for clinical application in 1983 for the prevention of transplanted organ rejection complications. Moreover, it is well recognized for treating some autoimmune diseases such as psoriasis and rheumatoid arthritis and is suggested for other conditions such as sepsis, endotoxemia, and myocardial ischemic/reperfusion injury (
4). Considering the rapid growth and high prevalence of these disorders, CyA has a unique and large market, necessitating the development of new economically efficient production methods. The CyA is reported to be produced by submerged culture fermentation, static fermentation, and solid-state fermentation by the fungus
T. inflatum. Several studies have reported the relationship between different fermentation parameters and CyA yield in
T. inflatum cultures. They revealed the effectiveness of carbon and nitrogen sources, the addition of minerals such as FeCl
3, ZnSO
4, and CoCl
2, and environmental factors such as pH, aeration, and agitation (
3). Moreover, adjusting each of the three culture stages (sporulation culture, growth culture, and production culture) could also increase the production of CyA by wild-type
T. inflatum (
5). Even adding insect hemolymph to the culture media of
T. inflatum has been shown to upregulate genes involved in CyA biosynthesis (
6).
In addition to fermentation optimization, the improvement of microbial strains is a primary method to maximize the productivity of CyA by
T. inflatum. This strain improvement can be achieved through conventional mutagenesis techniques, such as chemical and physical mutations. Beneficial effects of treatment with the chemical mutagens N-nitroso-N-methylurea and epichlorohydrin on the production level of CyA in
T. inflatum strains have been demonstrated (
3,
7). Random mutagenesis through UV radiation and protoplast fusion are other techniques that can significantly increase CyA productivity by
T. inflatum (
3,
8). The UV radiation is a well-known method for improving the yield of fungal metabolites and has been applied to other industrial fungal strains, such as
Aspergillus spp., to increase kojic acid production (
9).